Skip to main content
NCBI home page
Springer logoLink to Springer
. 2023 Jan 6;38(5):689–690. doi: 10.1007/s00380-022-02228-3

Correction to: Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study

Vincenzo Russo 1,✉,#, Alfredo Caturano 2,#, Federico Guerra 3, Federico Migliore 4, Giuseppe Mascia 5, Andrea Rossi 6, Martina Nesti 7, Vincenzo Ezio Santobuono 8, Emilio Attena 9, Gianfranco Tola 10, Luigi Sciarra 11, Giulio Conte 12, Alessandro Paoletti Perini 13, Pietro Francia 14, Gregory Dendramis 15, Zefferino Palamà 16, Stefano Albani 17, Andrea Ottonelli Ghidini 18, Leonardo Calò 11, Antonio D’Onofrio 19, Enrico Baldi 20; IBRYD Study Group
PMCID: PMC10085894  PMID: 36607387

Correction to: Heart and Vessels 10.1007/s00380-022-02204-x

In the original publication of the article, under acknowledgements, the below author’s names, affiliation information were missing and included in this article.

1. Nicolò Martini (Università degli Studi di Padova, Padua, Italy).

2. Chiara Carrozzi (IRCCS Policlinico San Matteo, Pavia, Italy).

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Vincenzo Russo, Email: v.p.russo@libero.it.

IBRYD Study Group:

Gerardo Nigro, Ferdinando Carlo Sasso, Luca Barca, Italo Porto, Pasquale Notarstefano, Maria Antonietta Ruocco, Livia Franchetti Pardo, Carmen Adducci, Nicola Berlier, Berardo Sarubbi, Alessandro Vicentini, Roberto Floris, Emanuele Romeo, Paolo Golino, Nicolò Martini, and Chiara Carrozzi

Articles from Heart and Vessels are provided here courtesy of Springer

RESOURCES